Tonix Pharmaceuticals Files 8-K
Ticker: TNXP · Form: 8-K · Filed: Apr 29, 2025 · CIK: 1430306
| Field | Detail |
|---|---|
| Company | Tonix Pharmaceuticals Holding Corp. (TNXP) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-disclosure, financial-reporting
TL;DR
TONIX filed an 8-K on 4/29/25 covering Reg FD, other events, and financials.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 29, 2025, to report on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company's principal executive offices are located at 26 Main Street, Suite 101, Chatham, New Jersey.
Why It Matters
This 8-K filing provides updates on Tonix Pharmaceuticals' corporate activities and financial reporting, which are important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Registrant
- April 29, 2025 (date) — Date of report
- 26 Main Street, Suite 101, Chatham, New Jersey, 07928 (location) — Principal executive offices
- Nevada (jurisdiction) — State of incorporation
- 26-1434750 (identifier) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing for Tonix Pharmaceuticals Holding Corp.?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits as of April 29, 2025.
When was the report filed and what is the earliest event date reported?
The report was filed on April 29, 2025, and the earliest event date reported is also April 29, 2025.
Where are Tonix Pharmaceuticals Holding Corp.'s principal executive offices located?
The principal executive offices of Tonix Pharmaceuticals Holding Corp. are located at 26 Main Street, Suite 101, Chatham, New Jersey, 07928.
What is the company's state of incorporation and IRS Employer Identification Number?
The company's state of incorporation is Nevada, and its IRS Employer Identification Number is 26-1434750.
What was the former name of Tonix Pharmaceuticals Holding Corp. and when did the name change occur?
The former name of Tonix Pharmaceuticals Holding Corp. was TAMANDARE EXPLORATIONS INC., and the date of the name change was March 20, 2008.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).